Avalo Therapeutics, Inc. (AVTX)
NASDAQ·Healthcare·Biotechnology
$6.86
-1.01%
Mkt Cap $379.16M
Analyst Ratings
Buy
9
Hold
2
Sell
0
Price Target (16 analysts)
$35.13
Range $10.00 – $60.00
Implied Upside
+412.1%
Consensus $35.13 vs current $6.86
NASDAQ·Healthcare·Biotechnology
$6.86
-1.01%
Mkt Cap $379.16M
Buy
9
Hold
2
Sell
0
Price Target (16 analysts)
$35.13
Range $10.00 – $60.00
+412.1%
Consensus $35.13 vs current $6.86